GBM
Clinical trials for GBM explained in plain language.
Never miss a new study
Get alerted when new GBM trials appear
Sign up with your email to follow new studies for GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer, that had come back after standard treatments. The goal was to see if VAL-083 could help patients live longer. However, the trial was stopped early after only 2 people enrolled, so…
Matched conditions: GBM
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Brain tumor drug penetration study halted early
Knowledge-focused TerminatedThis early-phase trial aimed to see how well the drug infigratinib reaches brain tumors in patients with recurrent high-grade glioma (a type of brain cancer) who were scheduled for surgery. Only 7 of the planned 20 participants were enrolled before the study was terminated. The m…
Matched conditions: GBM
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 17, 2026 05:27 UTC